Expertise in
9
conditions

Timothy J. Kleinig

1 Port Road, 
Adelaide, SA, AU 
Expertise in
9
conditions
1 Port Road, 
Adelaide, SA, AU 

Overview

Timothy Kleinig practices practicing medicine in Adelaide, Australia.

Mr. Kleinig is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Stroke, Thrombophlebitis, Mesenteric Venous Thrombosis, Thrombectomy, and Craniectomy.

He is actively involved in clinical research, co-authoring 248 peer reviewed articles and participating in 9 clinical trials.

Gender

Male

Locations

1 Port Road, Adelaide, SA 5000, Australia
Other Locations
Port Road, Adelaide, SA 5000, Australia
Haydown Rd & Oldham Rd, Elizabeth Vale, SA 5112, Australia
North Terrace, Adelaide, SA 5000, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
Enrollment Status: Completed
Publish Date: May 06, 2026
Intervention Type: Drug
Study Drug: Dornase Alfa
Study Phase: Phase 2
SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Enrollment Status: Completed
Publish Date: November 21, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units. A Phase II Randomised, Placebo-controlled, Investigator-driven Trial of Tranexamic Acid Within 2 Hours of Intracerebral Haemorrhage
STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units. A Phase II Randomised, Placebo-controlled, Investigator-driven Trial of Tranexamic Acid Within 2 Hours of Intracerebral Haemorrhage
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Drug: Tranexamic Acid
Study Phase: Phase 2
DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval Within 4.5 Hours of Stroke Onset
DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval Within 4.5 Hours of Stroke Onset
Enrollment Status: Completed
Publish Date: June 16, 2022
Intervention Type: Other
Study Phase: Phase 3
EXTEND-IA TNK: Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase Part 2
EXTEND-IA TNK: Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase Part 2
Enrollment Status: Completed
Publish Date: March 04, 2020
Intervention Type: Drug
Study Phase: Phase 2
STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial.
STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial.
Enrollment Status: Completed
Publish Date: February 26, 2020
Intervention Type: Drug
Study Phase: Phase 2
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Enrollment Status: Terminated
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
Extending the Time for Thrombolysis in Emergency Neurological Deficits
Extending the Time for Thrombolysis in Emergency Neurological Deficits
Enrollment Status: Completed
Publish Date: August 31, 2018
Intervention Type: Drug
Study Phase: Phase 3
Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase
Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase
Enrollment Status: Completed
Publish Date: March 30, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

248 Total Publications

Association of Successful Recanalization and Functional Outcomes in Minor Ischemic Stroke With Proven Occlusion: A Secondary Analysis of TEMPO-2 Trial.
Association of Successful Recanalization and Functional Outcomes in Minor Ischemic Stroke With Proven Occlusion: A Secondary Analysis of TEMPO-2 Trial.
Journal: Stroke
Published: June 19, 2026

Frequently Asked Questions about Timothy J. Kleinig

Is Timothy J. Kleinig a top-rated expert for Stroke?

MediFind is an objective health platform that identifies experts based on real-world data. Timothy J. Kleinig is classified as an Elite expert for Stroke, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Timothy J. Kleinig participate in research or clinical trials?

Yes. Timothy J. Kleinig has published 248 articles and abstracts on conditions like Stroke. You can view a list of Timothy J. Kleinig's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kleinig's expertise for a condition
ConditionClose
View All 32 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile